NCT00631917 - A Study Evaluating the Gastrointestinal (GI) Safety and Tolerability of Aliskiren Compared to Ramipril in Essential Hypertension | Biotech Hunter

Enrollment

774

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions

Hypertension

Interventions

DRUG

Aliskiren

Aliskiren 300 mg once a day

DRUG

Ramipril

Ramipril 10 mg once a day

OTHER

Placebo to Ramipril

Placebo capsules to match ramipril.

OTHER

Placebo to Aliskiren

Placebo tablets to match aliskiren.

Trial Locations (7)

Investigative Site, Kansas City

Investigative Site, Investigative Site